Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    Antiphospholipid Syndrome
Show Display Options
Download search resultsDownload the search results for:
Antiphospholipid Syndrome (53 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Interventions: Biological: Antiphospholipid antibody tests;   Biological: Thrombophilia bloodwork;   Other: Psychiatric evaluation
2 Completed A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention: Drug: Rituximab
3 Recruiting Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Condition: Antiphospholipid Syndrome
Intervention:
4 Completed Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
5 Completed Antiphospholipid Syndrome Collaborative Registry (APSCORE)
Condition: Antiphospholipid Syndrome
Intervention:
6 Recruiting Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
7 Unknown  Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
Condition: Antiphospholipid Syndrome
Intervention: Drug: Fluvastatin
8 Recruiting Rivaroxaban in Thrombotic Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention: Drug: Experimental: Rivaroxaban
9 Recruiting Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Syndrome
Intervention:
10 Active, not recruiting Pilot Study of Gut Commensals in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome (APS)
Intervention:
11 Withdrawn Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome
Condition: ANTIPHOSPHOLIPID SYNDROME
Intervention: Biological: Stem Cell Transplantation
12 Active, not recruiting Rivaroxaban for Patients With Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Interventions: Drug: Rivaroxaban;   Drug: acenocumarol
13 Recruiting Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome (APS)
Interventions: Drug: Hydroxychloroquine;   Drug: placebo
14 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
15 Recruiting Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome
Conditions: Antiphospholipid Syndrome;   Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
16 Completed Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
Condition: Antiphospholipid Syndrome
Intervention: Device: INR by point-of-care instruments and venopuncture
17 Recruiting Rivaroxaban for Antiphospholipid Antibody Syndrome
Condition: Antiphospholipid Antibody Syndrome
Intervention: Drug: Rivaroxaban
18 Completed The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
Condition: Antiphospholipid Syndrome
Intervention:
19 Completed
Has Results
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
Condition: Recurrent Abortion
Interventions: Drug: enoxaparin 40mg plus low dose aspirin;   Drug: Heparin calcium5,000 U twice daily plus low dose aspirin
20 Recruiting Use of Warfarin After the First Trimester in Pregnant Women With APS
Conditions: Recurrent Miscarriage;   Antiphospholipid Syndrome
Interventions: Drug: Enoxaparin;   Drug: Warfarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.